The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
作者信息
Alanio Alexandre, Dellière Sarah, Voicu Sebastian, Bretagne Stéphane, Mégarbane Bruno
机构信息
Laboratoire de Parasitologie-Mycologie AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Université de Paris, Institut Pasteur, CNRS UMR2000, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques.
Laboratoire de Parasitologie-Mycologie AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Université de Paris, Institut Pasteur, CNRS UMR2000, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques.
出版信息
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.034. Epub 2020 Nov 4.
Abstract
摘要
相似文献
1
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中耶氏肺孢子菌的存在情况。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.034. Epub 2020 Nov 4.
2
Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection.一名新诊断为HIV-1感染患者的耶氏肺孢子菌肺炎与严重急性呼吸综合征冠状病毒2合并感染
Clin Infect Dis. 2021 Apr 26;72(8):1487-1489. doi: 10.1093/cid/ciaa906.
3
Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?COVID-19 与 PJP 关系的叙述性综述：它代表合并感染还是定植？
Infection. 2021 Dec;49(6):1079-1090. doi: 10.1007/s15010-021-01630-9. Epub 2021 May 31.
4
Non-HIV Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection.非 HIV 免疫功能健全的 COVID-19 患者合并严重肺孢子菌肺炎感染。
Emerg Infect Dis. 2024 Sep;30(9):1948-1952. doi: 10.3201/eid3009.240615.
5
Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency.耶氏肺孢子菌与严重急性呼吸综合征冠状病毒2型合并感染作为X连锁严重联合免疫缺陷病的表现
Indian J Pediatr. 2023 Aug;90(8):832-833. doi: 10.1007/s12098-023-04661-2. Epub 2023 May 30.
6
A Case of COVID-19 and Coinfection.一例新型冠状病毒肺炎合并感染病例
Am J Respir Crit Care Med. 2020 Jul 1;202(1):136-138. doi: 10.1164/rccm.202003-0766LE.
7
Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges.COVID-19 大流行时代的肺孢子菌肺炎：相似性与挑战。
Trends Parasitol. 2021 Oct;37(10):859-862. doi: 10.1016/j.pt.2021.07.010. Epub 2021 Aug 4.
8
Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.一名25岁严重免疫功能低下患者同时感染新冠病毒和耶氏肺孢子菌肺炎。
Int J Infect Dis. 2020 Oct;99:119-121. doi: 10.1016/j.ijid.2020.07.061. Epub 2020 Aug 5.
9
[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].[新型冠状病毒肺炎后非艾滋病患者的耶氏肺孢子菌肺炎]
Rev Chilena Infectol. 2022 Jun;39(3):357-360. doi: 10.4067/s0716-10182022000200357.
10
Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib!非 COVID-19，吉非替尼治疗患者中勿忽视卡氏肺孢子菌！
Curr Oncol. 2021 Feb 21;28(1):961-964. doi: 10.3390/curroncol28010094.
引用本文的文献
1
Quantitative real time PCR for distinction between infection/colonization in hospitalized patients.定量实时 PCR 用于区分住院患者的感染/定植。
Front Cell Infect Microbiol. 2024 Sep 24;14:1426200. doi: 10.3389/fcimb.2024.1426200. eCollection 2024.
2
Fungi identified via next-generation sequencing in bronchoalveolar lavage fluid among patients with COVID-19: a retrospective study.COVID-19 患者支气管肺泡灌洗液中通过下一代测序鉴定的真菌：一项回顾性研究。
Eur J Med Res. 2024 Sep 17;29(1):463. doi: 10.1186/s40001-024-02054-5.
3
Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis.免疫功能低下患者呼吸道标本聚合酶链反应诊断卡氏肺孢子虫肺炎：系统评价和荟萃分析。
Clin Infect Dis. 2024 Jul 19;79(1):161-168. doi: 10.1093/cid/ciae239.
4
The effect of COVID-19 on the frequency of Pneumocystis jirovecii pneumonia: a monocentric, retrospective, and observational study.COVID-19 对卡氏肺孢子虫肺炎发生频率的影响：一项单中心、回顾性、观察性研究。
BMC Infect Dis. 2023 Oct 17;23(1):693. doi: 10.1186/s12879-023-08545-w.
5
Trends in the Epidemiology of Pneumonia in Immunocompromised Patients without HIV Infection.无HIV感染的免疫功能低下患者肺炎的流行病学趋势
J Fungi (Basel). 2023 Jul 31;9(8):812. doi: 10.3390/jof9080812.
6
Molecular and microscopy detection of in hospitalized patients during the COVID-19 pandemic.2019冠状病毒病大流行期间住院患者中的分子检测及显微镜检测
Front Med (Lausanne). 2023 Apr 6;10:1148320. doi: 10.3389/fmed.2023.1148320. eCollection 2023.
7
Previous corticosteroid exposure associates with an increased pneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter case-control study.既往使用皮质类固醇与HIV阴性患者肺炎死亡率增加相关：一项全球研究网络的多中心随访病例对照研究。
Ther Adv Infect Dis. 2023 Mar 14;10:20499361231159481. doi: 10.1177/20499361231159481. eCollection 2023 Jan-Dec.
8
Post-COVID-19 pneumonia cases from Pakistan: an observational study.来自巴基斯坦的新冠肺炎后肺炎病例：一项观察性研究。
Access Microbiol. 2023 Jan 5;5(1):acmi000406. doi: 10.1099/acmi.0.000406. eCollection 2023.
9
Infections Among COVID-19 Patients: A Case Series and Literature Review.新型冠状病毒肺炎患者的感染情况：病例系列及文献综述
Open Forum Infect Dis. 2023 Jan 27;10(2):ofad043. doi: 10.1093/ofid/ofad043. eCollection 2023 Feb.
10
pneumonia in COVID-19 patients: A comprehensive review.新型冠状病毒肺炎患者的肺炎：一项全面综述。
Heliyon. 2023 Feb;9(2):e13618. doi: 10.1016/j.heliyon.2023.e13618. Epub 2023 Feb 10.
本文引用的文献
1
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.血清（1-3）-β-D-葡聚糖检测对肺孢子菌肺炎的诊断准确性：系统评价和荟萃分析。
Clin Microbiol Infect. 2020 Sep;26(9):1137-1143. doi: 10.1016/j.cmi.2020.05.024. Epub 2020 May 30.
2
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
3
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
4
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality.流感病毒以及与 ICU 收治、肺部合并感染和 ICU 死亡率相关的因素。
J Crit Care. 2019 Apr;50:59-65. doi: 10.1016/j.jcrc.2018.11.013. Epub 2018 Nov 15.
7
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病：一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
8
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.ECIL 指南：血液恶性肿瘤和造血干细胞移植受者中肺孢子菌肺炎的诊断。
J Antimicrob Chemother. 2016 Sep;71(9):2386-96. doi: 10.1093/jac/dkw156. Epub 2016 May 12.
9
Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.β-D-葡聚糖检测对肺孢子菌肺炎的诊断准确性：一项荟萃分析。
Clin Microbiol Infect. 2013 Jan;19(1):39-49. doi: 10.1111/j.1469-0691.2011.03760.x. Epub 2012 Feb 13.
10
Pneumocystis jirovecii in general population.普通人群中的耶氏肺孢子菌。
Emerg Infect Dis. 2005 Feb;11(2):245-50. doi: 10.3201/eid1102.040487.
Zotero 插件